For more than 25 years, John has defended manufacturers
in product liability litigation in trial and appellate courts involving a multitude of products ranging from ATVs and RVs to suction vibrasorbers.
Carlton Fields has represented major manufacturing companies
in product liability litigation in state and federal courts nationwide for more than 30 years.
Defended aircraft manufacturer
in product liability litigation in state and federal courts arising from fatal crashes in general aviation.
Represented multinational pharmaceutical company
in product liability litigation in courts across the country and before the Judicial Panel on Multidistrict Litigation.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future
litigation, claims, and regulatory actions; 30) exposure to potential
product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions
in the industries and markets
in which United Technologies and Rockwell Collins operate
in the U.S. and globally and any changes therein, including financial market conditions, fluctuations
in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand
in construction and
in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges
in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new
products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies
in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including
in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including
in connection with the proposed acquisition of Rockwell; (7) delays and disruption
in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across
product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes
in political conditions
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate, including the effect of changes
in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates
in the near term and beyond; (16) the effect of changes
in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations
in the U.S. and other countries
in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result
in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including
in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted
in their operation of their businesses while the merger agreement is
in effect; (21) risks relating to the value of the United Technologies» shares to be issued
in connection with the pending Rockwell acquisition, significant merger costs and / or unknown
liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related
litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current
products and services, or develop new
products and services
in a timely manner or at competitive prices, including risks related to new
product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential
liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its
products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities
in BlackBerry's
products; risks related to
litigation, including
litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties
in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short
product life cycles that characterize the wireless communications industry.
Important factors that could cause actual results to differ materially from those expressed or implied by such forward - looking statements include, without limitation, possible
product defects and
product liability, risks related to international sales and potential foreign currency exchange fluctuations, the initiation or outcome of
litigation, acts or potential acts of terrorism, international conflicts, significant fluctuations of quarterly operating results, changes
in Canadian and foreign laws and regulations, continued acceptance of RIM's
products, increased levels of competition, technological changes and the successful development of new
products, dependence on third - party networks to provide services, dependence on intellectual property rights, and other risks and factors detailed from time to time
in RIM's periodic reports filed with the United States Securities and Exchange Commission, and other regulatory authorities.
He works
in law firm Wiggin & Dana's
litigation department with a practice focused on
product liability and aviation
litigation, amusement / leisure counseling and
litigation, and general business
litigation.
Paul Maloney is a trial lawyer who focuses his practice
in product liability, professional
liability, and commercial
litigation.
Mr. Leopold specializes
in consumer justice
litigation with a focus on complex
products liability, managed care, catastrophic injury and class action
litigation.
Brandon concentrates his practice
in general civil
litigation matters; including premises
liability,
product liability, construction and various insurance defense cases.
Among his other distinctions, Stewart has been recognized by The Best Lawyers
in America for the areas of Medical Malpractice Law (2013 — present), Personal Injury
Litigation (2014 — present) and
Product Liability Litigation (2016 — present).
He was recently named a 2018 Best Lawyers
in America «Lawyer of the Year»
in the practice area of
Product Liability Litigation — Plaintiffs
in West Palm Beach for his expertise.
The L.A. office opens with strong capabilities
in areas including cyber risk, sports and entertainment, and complex
product liability litigation, and will expand to cover the firm's full set of capabilities spanning all areas of civil
litigation, corporate transactions, regulatory compliance, and risk - avoidance counsel.
John has served as an expert witness regarding issues
in asbestos
litigation; he is a frequent speaker and commentator on
products liability litigation; and he has coordinated clients» lobbying efforts
in the U.S. House and Senate to create national asbestos legislation.
Stephen has a broad civil
litigation practice with extensive experience
in breach of trust claims, commercial disputes, construction liens, construction and environmental
liability claims, First Nations consultation rights
in land development, insurance coverage,
product liability, professional
liability and subrogation.
Wynn Shuford recently offered guidance on dealing with these «
Litigation Landmines» at the 2013 Fall Conference of the
Product Liability Advisory Council
in Las Vegas, Nevada.
To date, Tom has been lead counsel
in over 100 jury trials
in both Federal and State Court encompassing a wide variety of injuries and wrongful death resulting from
product liability, premises
liability, vehicular, trucking accidents, and bad faith
litigation.
Levy, now a member
in Eckert's Philadelphia office, has a broad
litigation practice covering
product liability, commercial
litigation, risk management, and white - collar criminal defense.
With more than 40 years of experience, James is a Florida Bar Board Certified Specialist
in Civil Trial law with extensive experience
in handling high - risk cases and regional
litigation management
in commercial, drug & medical device and
product liability cases.
Managing Partner Theodore J. Leopold specializes
in consumer justice
litigation with a focus on complex
products liability, managed care, catastrophic injury and class action
litigation.
Lana Olson focuses her practice on complex, high - stakes
litigation in a variety of areas, including environmental and toxic tort,
product liability, employment and catastrophic injury.
He practices
in the
Litigation Department with the Health Law and
Products and General
Liability practice groups.
At the Lynn Law Firm, he brings this broad experience and unique strategic perspective to represent clients
in personal injury, insurance coverage,
products liability, contract disputes, antitrust / intellectual property, and other civil
litigation matters.
Although my main focus area is on insurance defense
litigation, particularly motor vehicle negligence, construction defect
litigation, and professional malpractice, I also have experience
in business & commercial
litigation, patent / trademark / copyright law, trade secrets infringement, and premises /
product liability.
Prior to joining the firm, Cari represented national companies
in litigation for claims involving healthcare, personal injury, contract disputes, and
product liability matters.
Described as a «reliable partner providing an excellent service level», Hogan Lovells International LLP handles a broad range of contentious matters including commercial, corporate and contractual
litigation and is particularly well versed
in product liability.
John concentrates his practice on representing corporate clients
in tort defense,
products liability, mass torts, class actions, toxic torts, asbestos,
litigation management, food
liability, professional
liability, pharmaceutical and medical device
litigation, environmental
litigation, intellectual property
litigation, construction defect
litigation, general
liability, premises
liability, and business and insurance disputes.
Tom practices
in the area of civil
litigation focusing on corporate / commercial
litigation, securities
litigation,
product liability defence and class action defence.
His practice covers a range of
litigation, including commercial, class action defense,
product liability, mass tort, environmental, trade secret, insurance coverage, and real property title disputes
in state and federal courts.
Emma specializes
in civil
litigation, focusing primarily on commercial
litigation, environmental claims, insurance law, real estate
litigation, municipal
liability,
product liability and personal injury.
Jodi Mullis is a partner
in WSHB's Phoenix office, handling complex
litigation involving medical malpractice, elder care,
product liability, professional malpractice, wrongful death and construction defect matters.
Steptoe's toxic tort
litigation practice, which was recognized
in the 2014 and 2015 editions of The Legal 500 US for providing «exceptional skill and service,» defends toxic tort,
product liability and environmental claims nationwide for the chemical, petrochemical, aerospace, manufacturing, and agricultural industries.
We assist
in a wide range of controversies, including complex commercial
litigation and international arbitration, insurance coverage disputes,
product liability, trade secret misappropriation, commercial contract disputes, antitrust claims, intellectual property rights, professional
liability claims and
products litigation.
With deep experience
in product liability matters and class action
litigation, including catastrophic injury and wrongful death cases, as well as consumer fraud, he represents national and international companies, including manufacturers of motor vehicles, power tools, pharmaceuticals, clothing, glass
products, outdoor power equipment, and industrial machinery.
In addition to Commercial Litigation, Jennifer has experience in Oil and Gas, Real Estate, Products Liability and Intellectual Property La
In addition to Commercial
Litigation, Jennifer has experience
in Oil and Gas, Real Estate, Products Liability and Intellectual Property La
in Oil and Gas, Real Estate,
Products Liability and Intellectual Property Law.
Mr. Chamberlin practices
in the areas of commercial and injury related
litigation and trials, including
products liability, construction defect, medical malpractice, motor vehicle, commercial motor vehicle, premises
liability, insurance bad faith and construction related injuries.
We represent a broad range of clients
in products liability and complex tort
litigation.
This recognition is limited only to lawyers who have won million dollar verdicts and / or settlements
in areas including personal injury, medical malpractice,
product liability, environmental issues, employment
litigation, and more.
Jeff Aucoin is an experienced
litigation lawyer with a focused practice
in commercial leasing disputes, construction disputes, insurance defence, and
product liability matters.
He has represented a broad spectrum of clients
in products liability and class action matters, breach of warranty claims, wrongful death claims, tort and personal injury claims, professional
liability claims and other areas of civil
litigation.
«Good» law firm SKW Schwarz Rechtsanwälte represents its clients
in commercial and distribution law
litigation, frequently including cross-border elements, and
in product liability proceedings.
At the time of our calls most juniors were
in the large business & commercial
litigation (BCL) group; a couple were
in product liability; and there was one apiece
in criminal defense, employment & labor law, and government affairs.
Caterpillar
Product Liability Litigation: Mr. Leopold was co-lead counsel
in a class action lawsuit alleging Caterpillar sold diesel engines with defective exhaust emissions system that resulted
in power losses and shutdowns.
Prior to joining Theall Group LLP, Camille summered and articled at the Toronto office of a prominent national business law firm, gaining commercial
litigation experience
in class proceedings, injunctions, franchise disputes, professional
liability, employment law, municipal
liability and negligence /
product liability.
V Andre Sherman is a trial lawyer specializing
in the areas of
product liability, pharmaceutical mass torts, consumer and employment class actions, and business
litigation.
We regularly defend automobile, heavy truck, bus, locomotive, and aircraft manufacturers — as well as their component suppliers —
in high - stakes
product liability, commercial, and catastrophic injury
litigation.
Lum defends clients
in product liability and mass tort
litigation, putative class actions, personal injury cases, and long - term care facility and nursing home
litigation.
Kelly is a member of Lewis Wagner's
litigation group where she concentrates her practice
in insurance coverage and bad faith, construction, and
product liability.